{
    "clinical_study": {
        "@rank": "117833", 
        "arm_group": [
            {
                "arm_group_label": "Laser Treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Pulsed dye laser 595nm"
            }, 
            {
                "arm_group_label": "SHAM Treatment", 
                "arm_group_type": "Sham Comparator", 
                "description": "using the pulsed dye laser (PDL) laser without releasing a pulse"
            }
        ], 
        "brief_summary": {
            "textblock": "Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic\n      approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking\n      due to inconsistent design of available studies. The purpose of this study is to evaluate\n      the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low\n      risk anatomical sites in an evidence based study setting."
        }, 
        "brief_title": "Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "condition": "Basal Cell Carcinoma", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Carcinoma, Basal Cell"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histologically confirmed unpigmented sBCC on the trunk and extremities\n\n          -  maximal tumour diameter 30 mm\n\n        Exclusion Criteria:\n\n          -  Fitzpatrick skin type >III\n\n          -  pregnancy\n\n          -  previous BCC treatment within 4 weeks\n\n          -  coagulation disorders\n\n          -  photo sensitizing medication\n\n          -  any indication of poor compliance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02125669", 
            "org_study_id": "FF57/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Laser Treatment", 
                "description": "Pulsed dye laser 595nm", 
                "intervention_name": "Laser treatment", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "SHAM Treatment", 
                "description": "using the pulsed dye laser (PDL) laser without releasing a pulse", 
                "intervention_name": "SHAM-Treatment", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "basal cell carcinoma", 
            "laser surgery", 
            "pulsed dye laser", 
            "randomized controlled trial"
        ], 
        "lastchanged_date": "April 27, 2014", 
        "number_of_arms": "2", 
        "official_title": "The Role of the 595 nm Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas at Low Risk Anatomical Sites: Outcome of a Double Blind Randomized Placebo Controlled Trial", 
        "overall_official": [
            {
                "affiliation": "Hautklinik Darmstadt", 
                "last_name": "Maurizio Podda, Dr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hautklinik Darmstadt", 
                "last_name": "Syrus Karsai, Dr.", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Hautklinik Darmstadt", 
                "last_name": "Heiko Friedl", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "complete response", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02125669"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hautklinik Darmstadt", 
            "investigator_full_name": "Maurizio Podda", 
            "investigator_title": "PD Dr. med.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "questionnaire", 
                "measure": "patients satisfaction", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }, 
            {
                "description": "questionnaire", 
                "measure": "side effects", 
                "safety_issue": "Yes", 
                "time_frame": "9 months"
            }, 
            {
                "measure": "reduction of tumor diameter and tumor thickness", 
                "safety_issue": "No", 
                "time_frame": "9 months"
            }
        ], 
        "source": "Hautklinik Darmstadt", 
        "sponsors": {
            "collaborator": {
                "agency": "University Medicine Greifswald", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Hautklinik Darmstadt", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}